Metastases of cutaneous squamous cell carcinoma in organ transplant recipients - The SCOPE-ITSCC metastases study

Metastases of cutaneous squamous cell carcinoma in organ transplant recipients - The *SCOPE-ITSCC metastases study* - SCOPE-ITSCC metastases study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON39568

Enrollment

300

Registered

2012-07-11

Start date

2013-05-28

Completion date

Unknown

Last updated

2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin cancer squamous cell carcinoma

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Organ-transplant recipients (OTR). Histologically proven cutaneous invasive SCC at time of inclusion.

Exclusion criteria

Exclusion criteria: Lack of consent.

Design outcomes

Primary

Measure	Time frame
The primary outcome of the study is the development of metastases of cutaneous invasive SCC within 2 years and the time period until the first metastases is discovered.	—

Secondary

Measure	Time frame
Assessment of risk factors for the design of future case-control studies.	—

Countries

Netherlands

Outcome results